GT200800048A - HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES - Google Patents

HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES

Info

Publication number
GT200800048A
GT200800048A GT200800048A GT200800048A GT200800048A GT 200800048 A GT200800048 A GT 200800048A GT 200800048 A GT200800048 A GT 200800048A GT 200800048 A GT200800048 A GT 200800048A GT 200800048 A GT200800048 A GT 200800048A
Authority
GT
Guatemala
Prior art keywords
human antibodies
antibodies against
therapeutic uses
antibody molecules
human
Prior art date
Application number
GT200800048A
Other languages
Spanish (es)
Inventor
Emma Michelle Campbell
Sofia Parveen
Joe Buechler
Gunars Valkirs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to GT200800048A priority Critical patent/GT200800048A/en
Publication of GT200800048A publication Critical patent/GT200800048A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A MIEMBROS DE UNIÓN ESPECÍFICOS EN PARTICULAR, MOLÉCULAS DE ANTICUERPO INTERLEUCINA 13 (ANTI-IL-13) HUMANO Y ESPECÍFICAMENTE AQUELLAS QUE NEUTRALIZAN LA ACTIVIDAD DE IL-13. ADEMÁS SE REFIERE A MÉTODOS PARA UTILIZAR MOLÉCULAS DEL ANTICUERPO ANTI-IL-13 EN EL DIAGNÓSTICO O TRATAMIENTO DE TRASTORNOS RELACIONADOS CON IL-13, TALES COMO ASMA, DERMATITIS ATÓPICA, RINITIS ALÉRGICA, FIBROSIS, ENFERMEDAD INFLAMATORIA DEL INTESTINO Y LINFOMA DE HODGKIN.THIS INVENTION CONCERNS SPECIFIC UNION MEMBERS IN PARTICULAR, INTERLEUCINE ANTIBODY MOLECULES 13 (ANTI-IL-13) HUMAN AND SPECIFICALLY THOSE THAT NEUTRALIZE THE ACTIVITY OF IL-13. FURTHER REFERRED TO METHODS TO USE ANTI-IL-13 ANTIBODY MOLECULES IN THE DIAGNOSIS OR TREATMENT OF IL-13-RELATED DISORDERS, AS ASTHMA, ATOPIC DERMATITIS, ALLERGIC RHINITIS, INFLATINATORY INFLATABILITY AND INFLATINITY.

GT200800048A 2008-04-21 2008-04-21 HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES GT200800048A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GT200800048A GT200800048A (en) 2008-04-21 2008-04-21 HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GT200800048A GT200800048A (en) 2008-04-21 2008-04-21 HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES

Publications (1)

Publication Number Publication Date
GT200800048A true GT200800048A (en) 2008-09-10

Family

ID=47044107

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800048A GT200800048A (en) 2008-04-21 2008-04-21 HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES

Country Status (1)

Country Link
GT (1) GT200800048A (en)

Similar Documents

Publication Publication Date Title
ECSP088388A (en) HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES
ECSP088690A (en) ANTIBODIES FOR TIMICA STROMAL LYMPHOPOYETINE (TSLP) AND USES OF THE SAME
AR122833A2 (en) ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES
DOP2008000018A (en) ANTI-IGE ANTIBODIES
MX2009007406A (en) Anti-il-13 antibody formulations and uses thereof.
CO6940374A2 (en) Compositions, uses and methods for the treatment of disorders and metabolic diseases
MY184241A (en) Human antibodies to gfr?3 and methods of use thereof
BR112014005110A2 (en) substituted ring pyrimidines and their use
WO2012106407A3 (en) Diagnostic and therapeutic methods and products related to anxiety disorders
CL2009000905A1 (en) Edible composition comprising bifidobacterium longum atcc baa-999; and its use to treat or prevent anxiety and / or anxiety-related disorders.
BR112014005358A8 (en) COMPOSITIONS COMPRISING TRPV1 SELECTIVE AGONIST AND THEIR USES
JO3199B1 (en) Substituted 5-fluoro-1H-pyrazolopyridines and their use
MX2022004300A (en) Composition and method for diagnosis and treatment of diseases associated with neurite degeneration.
WO2007111993A3 (en) Polyamine analogs as therapeutic agents for skin diseases
UA105405C2 (en) Humanized anti-il-22ra antibody
UY32489A (en) ANTIBODY MOLECULES THAT HAVE UNION SPECIFICITY FOR HUMAN IL-13
MX355394B (en) Cd89 activation in therapy.
ECSP21017619A (en) AGONIST ANTIBODIES AGAINST CD200R AND ITS USES
GT200800048A (en) HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES
TNSN08175A1 (en) Human antibodies against il-13 and therapeutic uses
TH101957A (en) Antibodies against human IL-13 and Ayurvedic use